From Practice-Changing Data to Future Innovation, Patient Outcome
WEBDate: 13 Sep 2024. Studies presented at the ESMO Congress 2024 bring immunotherapy into new disease areas with high unmet need. Novel agents and technologies show promise in various indications and offer a glimpse into the future of oncology.
ESMO 2024 Press Conference
WEBSep 13, 2024 · The ESMO Congress 2024 will hold a press conference to introduce and discuss the “Eyes to the Future” Presidential Symposium 3, that will be presenting prominent approaches that have the potential to become increasingly effective and influential components of cancer treatment in the (near) future.
ESMO Congress 2024
WEBSep 13, 2024 · The ESMO Congress is a globally influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2024 disseminated the latest cutting-edge data, provided high quality education and excellent networking opportunities for oncologists and other ...
ESMO 2024: breaking news and abstracts - Oncology Central
WEBWith ESMO 2024 (13–17 September, Barcelona, Spain) underway, we're excited to bring you the latest breaking news, late-breaking abstracts and highlights from this year's congress. From groundbreaking trials to innovative research developments, this collection captures the most impactful moments. Stay tuned as we dive into the stories that ...
ESMO 2024: Four Key Takeaways from Europe’s Biggest Oncology …
WEB2 days ago · Europe, ESMO, Cancer, Oncology, Immunotherapy, ADCs, AstraZeneca, MSD, Daiichi Sankyo. This year’s European Society of Medical Oncology (ESMO) was the largest ever. Over 33,000 people attended ESMO Congress 2024 at Barcelona’s cavernous Fira Gran Via conference centre, where 5,000 abstracts were presented and 600 expert speakers took to the ...
ESMO 2024: An immunotherapy milestone, studying young-onset …
WEB5 days ago · Sept. 16, 2024. Europe Correspondent. This is the online edition of ESMO in 30 Seconds, a pop-up newsletter from the European Society for Medical Oncology’s annual meeting in Barcelona, Spain ...
ESMO Congress 2024 - Daily Reporter
WEBAdding durvalumab to neoadjuvant chemotherapy improves survival in muscle-invasive bladder cancer. Practice changing results of event-free survival and overall survival are reported from the NIAGARA study. 15 Sept 2024.
ESMO Congress 2024 - Daily Reporter
WEBSep 6, 2024 · Taxane- and anthracycline-sparing regimens show promise in high-risk, early-stage breast cancer. 14 Sept 2024. 1. 2. The Daily Reporter is a service from ESMO, Europe’s leading medical oncology society.
ESMO Congress 2024
WEB4 days ago · ESMO Congress 2024. 13 - 17 Sep 2024. Barcelona, Spain. Resources are available according to the presenters' agreement to release them. Abstracts, ePosters and Guidelines sessions are open access. Slides and webcasts are reserved to ESMO Members and registered Delegates. The copyright protected educational resources from this event are for ...
Comprehensive cancer research from Dana-Farber to lead ESMO Congress 2024
WEBSep 11, 2024 · A full list of Dana-Farber Presentations at the 2024 ESMO Congress is available here: Dana-Farber Presentations at ESMO24. For all ESMO-related media inquiries, contact Victoria Warren (617-939-5531, [email protected]). Follow the meeting live on X using the hashtag #ESMO24 and follow Dana-Farber News on X at @DanaFarberNews.
- Some results have been removed
Skip to content